Tower Research Capital (TRC)’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.75K Sell
4,277
-1,580
-27% -$3.6K ﹤0.01% 3981
2025
Q1
$9.08K Buy
5,857
+1,127
+24% +$1.75K ﹤0.01% 3823
2024
Q4
$11.1K Buy
4,730
+1,790
+61% +$4.21K ﹤0.01% 3748
2024
Q3
$10.7K Sell
2,940
-10,397
-78% -$37.7K ﹤0.01% 3728
2024
Q2
$46.4K Buy
13,337
+11,721
+725% +$40.8K ﹤0.01% 3164
2024
Q1
$10.3K Sell
1,616
-8,177
-83% -$52.2K ﹤0.01% 3714
2023
Q4
$63.1K Sell
9,793
-7,903
-45% -$50.9K ﹤0.01% 2976
2023
Q3
$41.2K Sell
17,696
-7,680
-30% -$17.9K ﹤0.01% 2708
2023
Q2
$60.4K Sell
25,376
-4,352
-15% -$10.4K ﹤0.01% 2427
2023
Q1
$55K Buy
29,728
+10,603
+55% +$19.6K ﹤0.01% 2395
2022
Q4
$36K Buy
19,125
+12,618
+194% +$23.8K ﹤0.01% 2576
2022
Q3
$14K Buy
6,507
+3,053
+88% +$6.57K ﹤0.01% 4204
2022
Q2
$10K Buy
3,454
+480
+16% +$1.39K ﹤0.01% 4427
2022
Q1
$13K Sell
2,974
-1,426
-32% -$6.23K ﹤0.01% 3955
2021
Q4
$23K Sell
4,400
-1,648
-27% -$8.62K ﹤0.01% 3498
2021
Q3
$40K Buy
6,048
+3,462
+134% +$22.9K ﹤0.01% 3124
2021
Q2
$17K Sell
2,586
-494
-16% -$3.25K ﹤0.01% 4026
2021
Q1
$17K Buy
3,080
+1,468
+91% +$8.1K ﹤0.01% 3992
2020
Q4
$14K Sell
1,612
-3,591
-69% -$31.2K ﹤0.01% 4087
2020
Q3
$61K Buy
5,203
+4,313
+485% +$50.6K ﹤0.01% 3449
2020
Q2
$14K Buy
890
+259
+41% +$4.07K ﹤0.01% 3858
2020
Q1
$4K Sell
631
-1,596
-72% -$10.1K ﹤0.01% 2342
2019
Q4
$29K Buy
+2,227
New +$29K ﹤0.01% 1670
2019
Q2
Sell
-3,041
Closed -$96K 3653
2019
Q1
$96K Buy
+3,041
New +$96K 0.01% 1441
2018
Q4
Sell
-68
Closed -$2K 3809
2018
Q3
$2K Buy
+68
New +$2K ﹤0.01% 3405